CG Oncology, Inc. (CGON)
56.65
+2.25
(+4.14%)
USD |
NASDAQ |
Jun 09, 16:00
56.65
0.00 (0.00%)
After-Hours: 20:00
CG Oncology SG&A Expense (Quarterly) : 20.78M for March 31, 2026
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Cogent Biosciences, Inc. | 28.24M |
| Vera Therapeutics, Inc. | 39.12M |
| Arrowhead Pharmaceuticals, Inc. | 41.74M |
| Oncolytics Biotech, Inc. | 4.729M |
| Sangamo Therapeutics, Inc. | 6.818M |